Abstract
The dermis is the portal of entry for most vector-transmitted pathogens, making the host’s immune response at this site critical in mitigating the magnitude of infection. For malaria, antibody-mediated neutralization ofPlasmodiumparasites in the dermis was recently demonstrated. However, surprisingly little is known about the mechanisms that govern antibody transport into the skin. Since the neonatal Fc receptor (FcRn) has been shown to transcytose IgG into various tissues, we sought to understand its contribution to IgG transport into the skin and antibody-mediated inhibition ofPlasmodiumparasites following mosquito bite inoculation. Using confocal imaging, we show that the transport of an anti-Langerin mAb into the skin occurs but is only partially reduced in mice lacking FcRn. To understand the relevance of FcRn in the context of malaria infection, we use the rodent parasitePlasmodium bergheiand show that passively-administered anti-malarial antibody in FcRn deficient mice, does not reduce parasite burden to the same extent as previously observed in wildtype mice. Overall, our data suggest that FcRn plays a role in the transport of IgG into the skin but is not the major driver of IgG transport into this tissue. These findings have implications for the rational design of antibody-based therapeutics for malaria as well as other vector-transmitted pathogens.
Funder
National Institutes of Health
Bloomberg Family Foundation
Emergent BioSolutions Fellowship
Office of the Director of the National Institutes of Health
Publisher
Public Library of Science (PLoS)